(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Post-thoracotomy Pain Syndrome
University of Maryland, BaltimoreSmall moleculeN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Post-thoracotomy Pain Syndrome cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Onabotulinum Toxin A Allan Vestergaard Danielsen, MD | Phase 1/2 | CC |
FENTANYL University of Maryland, Baltimore | N/A | D |
Same molecule, other indications
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →